What is the debt of ContraFect this year?
ContraFect has a debt level of -8.91 USD this year.
ContraFect Debt 2024
ContraFect Debt
-8.91 USD
Ticker
CFRX
ISIN
US2123263004
WKN
A2PZKK
In 2024, ContraFect's total debt was -8.91 USD, a -46.49% change from the -16.65 USD total debt recorded in the previous year.
ContraFect Aktienanalyse
What does ContraFect do?
The company ContraFect Corp was founded in 2008 by the renowned immunologist Dr. Robert Nowinski, with the aim of developing groundbreaking therapies for the treatment of infectious diseases. The company is a biopharmaceutical company focused on the development of antibiotic alternatives to be effective against bacteria that have become resistant to traditional antibiotics. The business model of ContraFect Corp is based on an innovative approach that harnesses the body's immune system defenses. Specifically, artificial proteins are developed to combat bacterial infections. These proteins are called "lysins." They work by selectively targeting specific bacterial cells, causing them to dissolve and die. ContraFect Corp is divided into various divisions, each specializing in a specific area of infection control. One division is "Lysin Discovery and Development," which focuses on the discovery of new lysins to combat bacteria. Another important division is "Research and Development," which aims to develop new therapies for the treatment of bacterial infections. The company also has specialized programs for treating specific bacterial infections such as cystic fibrosis. The company has developed a range of products that can be used to treat infectious diseases. The most important product of ContraFect Corp is CF-301, a lysin developed against Staphylococcus aureus - better known as "MRSA" or "hospital-acquired infection." This is an extremely dangerous strain of bacteria that conventional antibiotics increasingly show no effect against. The drug has shown promising results in clinical trials and is currently in Phase 3 of clinical development, nearing approval by the US Food and Drug Administration (FDA). Overall, ContraFect Corp has developed a variety of lysins that are effective against different types of bacteria. These lysins are administered in the form of injections or inhalers for rapid effect. In addition to the treatment of infectious diseases, ContraFect Corp also has a promising program in the early stages of research for the treatment of cystic fibrosis. ContraFect Corp has emerged as one of the leading companies in the field of antibiotic alternatives. The company is persistently working to develop new and innovative treatments to minimize the risks of antibiotic resistance. The company employs state-of-the-art technologies to ensure the effectiveness and safety of its products. Thanks to significant investments and promising results in clinical trials, the future of ContraFect Corp seems very promising. ContraFect ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding ContraFect's Debt Structure
ContraFect's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing ContraFect's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to ContraFect’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in ContraFect’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about ContraFect Stock
What was the debt of ContraFect compared to the previous year?
The debt of ContraFect has increased by -46.49% compared to the previous year dropped.
What are the consequences of high debt for investors in ContraFect?
High debt can pose a risk for investors of ContraFect, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of ContraFect?
Low debt means that ContraFect has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from ContraFect affect the company?
An increase in debt of ContraFect can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of ContraFect affect the company?
A reduction in debt of ContraFect can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of ContraFect?
Some factors that can influence the debt of ContraFect include investments, acquisitions, operating costs, and revenue development.
Why are the debts of ContraFect so important for investors?
The debts of ContraFect are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can ContraFect take to change the debt?
To change the debt, ContraFect can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does ContraFect pay?
Over the past 12 months, ContraFect paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ContraFect is expected to pay a dividend of 0 USD.
What is the dividend yield of ContraFect?
The current dividend yield of ContraFect is .
When does ContraFect pay dividends?
ContraFect pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ContraFect?
ContraFect paid dividends every year for the past 0 years.
What is the dividend of ContraFect?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ContraFect located?
ContraFect is assigned to the 'Health' sector.
Wann musste ich die Aktien von ContraFect kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ContraFect from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.
When did ContraFect pay the last dividend?
The last dividend was paid out on 6/11/2024.
What was the dividend of ContraFect in the year 2023?
In the year 2023, ContraFect distributed 0 USD as dividends.
In which currency does ContraFect pay out the dividend?
The dividends of ContraFect are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ContraFect stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ContraFect
Our stock analysis for ContraFect Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ContraFect Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
